Trial Profile
Exploratory Study to Optically Visualise Activated Neutrophils and the Proto-oncogene, c-MET, in Lung Cancer Using DUAL Colour Fibre-based Endomicroscopy
Status:
Discontinued
Phase of Trial:
Phase 0
Latest Information Update: 06 Dec 2023
Price :
$35
*
At a glance
- Drugs EMI-137 (Primary)
- Indications Lung cancer
- Focus Biomarker; Diagnostic use
- Acronyms Dual
- 28 Nov 2023 Status changed from recruiting to discontinued.
- 27 Apr 2021 Planned End Date changed from 20 Mar 2021 to 20 Mar 2022.
- 27 Apr 2021 Planned primary completion date changed from 20 Dec 2020 to 20 Dec 2021.